Streetbeat News

Stock Prices

CRM

Salesforce has been recruiting back former executives to help reignite growth. The company has brought back at least eight executives this year, including Ariel Kelman, former marketing executive at Amazon Web Services and Oracle, and Miguel Milano, who led sales in major international markets for Salesforce. The company is revamping its strategy around sales and marketing after cutting 10% of its workforce this year. Salesforce's stock has risen 62% this year, double the gains for the Nasdaq, despite a challenging economy and slowing growth.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 8:14 pm

IBEX

IBEX Limited (NASDAQ:IBEX) announced a $30 million share repurchase program, which may be executed over the next 6 months. The company's management believes that the current market value of their shares does not accurately reflect the value of the company. This announcement follows a significant drop in the stock's price due to worse-than-expected Q4 financial results and below-estimate revenue guidance for Q1 and full-year 2024.

Portfolio Pulse from Ryan Gustafson

September 18, 2023 | 8:10 pm

INDI

indie Semiconductor has acquired EXALOS AG for approximately $45 million, paid in 6.6 million indie Class A common shares. The deal also includes the potential for EXALOS equity holders to earn up to an additional $20 million in cash or indie Class A common shares, based on performance targets over the next 24 months. The acquisition expands indie's ADAS and User Experience portfolio and is expected to be financially neutral in 2023 and accretive in 2024.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 8:08 pm

TMBR

Timber Pharmaceuticals has announced that the New York Stock Exchange (NYSE) has accepted its plan to regain listing compliance. This comes after the company was previously at risk of being delisted due to non-compliance with NYSE's listing standards.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 8:08 pm

SFIX

Stitch Fix reported Q4 losses of $(0.24) per share, missing the analyst consensus estimate of $(0.21) by 14.29%. However, the company's quarterly sales of $375.80 million beat the analyst consensus estimate of $371.36 million by 1.20%. This represents a 63.08% increase in losses and a 22.02% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 8:06 pm

KNTE

Shares of Kinnate Biopharma have been halted due to pending news. Further details are yet to be released.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 8:05 pm

HSTO

Shares of Histogen Inc. (HSTO) have been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 8:03 pm

OXY

Over the last quarter, Occidental Petroleum (NYSE:OXY) has received various analyst ratings. The average price target is $69.6, compared to its current price of $66.165, implying an upside. However, this average represents a 0.57% decrease from the previous average price target of $70.00.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 8:00 pm

SCHW

Analysts have provided various ratings for Charles Schwab (NYSE:SCHW) within the last quarter, with a majority leaning towards bullish or somewhat bullish. The average 12-month price target for Charles Schwab is $71.75, which has increased by 5.41% over the past month.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 8:00 pm

SM

SM Energy (NYSE:SM) has received a mix of bullish and indifferent ratings from analysts in the last quarter. The average price target set by these analysts is $45.43, which is higher than the current price of $39.53, implying an upside. The average price target has increased by 8.92% over the past month.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 8:00 pm